Molecular Diagnostics Global Market Report 2022: Increase in Prevalence of Cancer, Infectious Disease, and Genetic Disorders Bolstering Sector

News provided by

Nov 01, 2022, 08:00 ET

DUBLIN, Nov. 1, 2022 /PRNewswire/ -- The "Molecular Diagnostics Market By Type, By Technology, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The global molecular diagnostics market was valued at $9,160.61 million in 2020 and is projected to reach $23,905.56 million by 2030, registering a CAGR of 9.86% from 2021 to 2030.

Molecular diagnosis is a process to identify a disease at the molecular level, such as proteins, DNA, and RNA, in a tissue or fluid. Certain tools are used to detect specific sequences in DNA or RNA that may or may not be associated with the disease, which include single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others, which are used for diagnosis and prediction of the various infectious diseases, cancer, and other genetic disorders.

The main driving factors that drive the growth of the molecular diagnostics market include, increase in prevalence of cancer, infectious disease, and genetic disorders and increase in awareness about early diagnosis of these diseases among population.

In addition, increase in awareness and acceptance of personalized medicines and growth in the biomarker identification, further supplement the global molecular diagnostics market growth.

Conversely, stringent regulatory requirements for the approval of new molecular diagnostics techniques are expected to obstruct the growth of the market during forecast years. On the other hand, increase in adoption of the molecular diagnostics in the emerging economies is are expected to offer profitable opportunities for the growth of the market during the forecast period.

Key Market Segments

By Technology

Polymerase Chain Reaction (PCR)
Hybridization
DNA sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

By Application

Infectious diseases
Oncology
Genetic testing
Blood screening
Others

By Type

Instruments
Reagents
Software Services

By End User

Hospital
Reference Labortories
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Asia-Pacific
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: MOLECULAR DIAGNOSTICS MARKET, BY TYPE

CHAPTER 5: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

CHAPTER 6: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION

CHAPTER 7: MOLECULAR DIAGNOSTICS MARKET, BY END USER

CHAPTER 8: MOLECULAR DIAGNOSTICS MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

Companies Mentioned